Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases, including type 1 diabetes ...

Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization and SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical ...

Detailed price information for Sab Biotherapeutics Inc (SABS-Q) from The Globe and Mail including charting and trades.

New data from ADA 2026 reveal that assumptions around age, weight, and gestational history are leaving too many T1D patients misclassified — and the clinical consequences are preventable. Our modern ...

Under the terms of MacroGenics’ agreement with Sanofi, the recent FDA approval triggered a $24.5 million regulatory milestone payable to MacroGenics. The Company remains eligible to receive up to $305 ...

NEW YORK, June 12, 2026 /PRNewswire/ -- Breakthrough T1D, the leading global type 1 diabetes (T1D) research and advocacy organization, applauds today's decision from the U.S. Food and Drug ...

Add Yahoo as a preferred source to see more of our stories on Google. AGAWAM, Mass. (WWLP) – The Breakthrough T1D walk was held Sunday morning to help raise funds and raise awareness for those with ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen by an independent group of researchers. The Nature Index provides absolute Count of ...

(WXYZ) — Breakthrough T1D, formerly known as JDRF, is hosting its annual Detroit Promise Ball on Friday, May 15, at Michigan Central Station. The annual ball helps ...

Add Yahoo as a preferred source to see more of our stories on Google. ANKENY, Iowa — Thousands of Iowans will gather next month for a walk that's about more than steps. It's about hope. The ...